Results 61 to 70 of about 5,756 (158)
Journal of Veterinary Internal Medicine, 2014 Background Ivabradine is a negative chronotropic drug with minimal effects on central hemodynamics. Its effect on dynamic obstruction of the left ventricular outflow tract (LVOT) in cats with hypertrophic cardiomyopathy (HCM) remains unknown.
K.A. Blass +4 more
doaj +1 more source
Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine
Indian Heart Journal, 2018 Background: Heart rate (HR) reduction is of benefit in chronic heart failure (HF). The effect of heart rate reduction using Ivabradine on various echocardiographic parameters in dilated cardiomyopathy has been less investigated.
Deep Chandh Raja +8 more
doaj +1 more source
Ivabradine and the SIGNIFY conundrum [PDF]
European Heart Journal, 2015 This editorial refers to ‘Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study’[†][1], by K. Fox et al ., on page 3291. Stable angina is a prevalent and disabling condition that occurs in 10–14% of those aged 65–84 years,1 with population studies suggesting ...
openaire +3 more sources
IVABRADINE OUTSIDE THE CLINICAL GUIDELINES: INTEREST OF A PRACTITIONER
Российский кардиологический журнал, 2018 The article is focused on the data concerning the influence of ivabradine on myocardial electrophysiology in experimental and clinical studies. It is shown that ivabradine decreases ventricular rate in chronic atrial fibrillation, and prevents the ...
E. I. Tarlovskaya
doaj +1 more source
Rambam Maimonides Medical Journal, 2015 Background: Postural tachycardia syndrome (POTS) is a common form of chronic orthostatic intolerance. The remarkable increase in heart rate (HR) upon standing is the hallmark of this syndrome.
Merav Barzilai, Giris Jacob
doaj +1 more source
Российский кардиологический журнал, 2018 The review is focused on the role of ivabradine in percutaneous coronary intervention (PCI) and coronary bypass grafting (CBG) in coronary heart disease patients (CHD) with stable angina.
D. M. Aronov, M. G. Bubnova
doaj +1 more source
The clinical and economic efficiency of treatment in patients with chronic heart failure
КардиоСоматика, 2013 Objective: to study the clinical and economic benefits of adding ivabradine to standard therapy for chronic heart failure (CHF). Subjects and methods.
E. I Tarlovskaya, S. V Malchikova
doaj
Drug Design, Development and Therapy, 2013 Andreas O Doesch,1 Susanne Mueller,1 Christian Erbel,1 Christian A Gleissner,1 Lutz Frankenstein,1 Stefan Hardt,1 Arjang Ruhparwar,2 Philipp Ehlermann,1 Thomas Dengler,3 Hugo A Katus1 1Department of Cardiology, 2Department of Cardiovascular Surgery ...
Doesch AO +9 more
doaj
Evaluation of Clinical outcomes of Generic versus Reference Ivabradine in Heart Failure Patients
Archives of Pharmaceutical Sciences Ain Shams University, 2020 Economic benefits associated with usage of generic drugs have been suggested to increase patients’ adherence to their medications and to improve patients’ health outcomes.
Hadeer Eid +5 more
doaj